The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease
Open accessAbstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in the current COVID-19 pandemic. Worldwide this disease has infected over 2.5 million individuals with a mortality rate ranging from 5 to 10%. There are several efforts going on in the drug discovery to control the SARS-CoV-2 viral infection. The main protease (MPro) plays a critical role in viral replication and maturation, thus can serve as the primary drug target. To understand the structural evolution of MPro, we have performed phylogenetic and Sequence Similarity Network analysis, that depicted divergence of Coronaviridae MPro in five clusters specific to viral hosts. This clustering was corroborated with the comparison of MPro structures. Furthermore, it has been observed that backbone and binding site conformations are conserved despite variation in some of the residues. These attributes can be exploited to repurpose available viral protease inhibitors against SARS-CoV-2 MPro. In agreement with this, we performed screening of ∼7100 molecules including active ingredients present in the Ayurvedic anti-tussive medicines, anti-viral phytochemicals and synthetic anti-virals against SARS-CoV-2 MPro as the primary target. We identified several natural molecules like δ-viniferin, myricitrin, taiwanhomoflavone A, lactucopicrin 15-oxalate, nympholide A, afzelin, biorobin, hesperidin and phyllaemblicin B that strongly binds to SARS-CoV-2 MPro. Intrestingly, these molecules also showed strong binding with other potential targets of SARS-CoV-2 infection like viral receptor human angiotensin-converting enzyme 2 (hACE-2) and RNA dependent RNA polymerase (RdRp). We anticipate that our approach for identification of multi-target-directed ligand will provide new avenues for drug discovery against SARS-CoV-2 infection.Communicated by Ramaswamy H. Sarma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
Tamura, K., Stecher, G., Peterson, D., Filipski, A., & Kumar, S. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst197 · Cited by 47,205
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 25,486
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Daina, A., Michielin, O., & Zoete, V. (2017) · Scientific Reports · doi:10.1038/srep42717 · Cited by 18,367
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Cappello, V., Marchetti, L., Parlanti, P., Landi, S., Tonazzini, I., Cecchini, M., Piazza, V., & Gemmi, M. (2016) · Scientific Reports · doi:10.1038/s41598-016-0001-8 · Cited by 13,097
Wiederstein, M., & Sippl, M. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm290 · Cited by 5,909
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661 · cited 8×
“Furthermore, hACE2 was prepared for docking, with a grid dimension of 20 Â 38 x 24 Å around the viral spike protein recognition residues (K31, E35, D38, M82, K353) (Shang et al., 2020) .”
BackgroundMethodInfluentialDali server: conservation mapping in 3D
Holm, L., & Rosenstr�m, P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq366 · Cited by 3,640
PubChem 2019 update: improved access to chemical data
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1033 · Cited by 3,249
Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020) · Science · doi:10.1126/science.abb3405 · Cited by 2,895
Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.008 · Cited by 2,330
Guo, J., Huang, F., Liu, J., Chen, Y., Wang, W., Cao, B., Zou, Z., Liu, S., Pan, J., Bao, C., et al. (2016) · Scientific Reports · doi:10.1038/srep21230 · Cited by 2,148
Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs
Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003) · Science · doi:10.1126/science.1085658 · Cited by 1,728
Structure of the RNA-dependent RNA polymerase from COVID-19 virus
Gao, Y., Yan, L., Huang, Y., Liu, F., Zhao, Y., Cao, L., Wang, T., Sun, Q., Ming, Z., Zhang, L., et al. (2020) · Science · doi:10.1126/science.abb7498 · Cited by 1,609
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,597
COVID-19: towards controlling of a pandemic
Bedford, J., Enria, D., Giesecke, J., Heymann, D. L., Ihekweazu, C., Kobinger, G., Lane, H. C., Memish, Z., Oh, M.-D., Sall, A. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30673-5 · Cited by 1,545
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Dong, L., Hu, S., & Gao, J. (2020) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2020.01012 · Cited by 1,390
Recent Advances and Uses of Grape Flavonoids as Nutraceuticals
Georgiev, V., Ananga, A., & Tsolova, V. (2014) · Nutrients · doi:10.3390/nu6010391 · Cited by 487
Yu, M.-S., Lee, J., Lee, J. M., Kim, Y., Chin, Y.-W., Jee, J.-G., Keum, Y.-S., & Jeong, Y.-J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.081 · Cited by 422
Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1752802 · Cited by 415
Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1753577 · Cited by 343
New England Journal of Medicine,
(1964) · JAMA · doi:10.1001/jama.1964.03060180110053 · Cited by 326
Conservation of substrate specificities among coronavirus main proteases
Hegyi, A., & Ziebuhr, J. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-3-595 · Cited by 322
Hasan, A., Paray, B. A., Hussain, A., Qadir, F. A., Attar, F., Aziz, F. M., Sharifi, M., Derakhshankhah, H., Rasti, B., Mehrabi, M., et al. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1754293 · Cited by 293
A second, non‐canonical RNA‐dependent RNA polymerase in SARS Coronavirus
Imbert, I., Guillemot, J., Bourhis, J., Bussetta, C., Coutard, B., Egloff, M., Ferron, F., Gorbalenya, A. E., & Canard, B. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601368 · Cited by 277
Gupta, M. K., Vemula, S., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1751300 · Cited by 270
Network analyses structure genetic diversity in independent genetic worlds
Halary, S., Leigh, J. W., Cheaib, B., Lopez, P., & Bapteste, E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908978107 · Cited by 263
Coronaviruses: a paradigm of new emerging zoonotic diseases
Salata, C., Calistri, A., Parolin, C., & Palù, G. (2019) · Pathogens and Disease · doi:10.1093/femspd/ftaa006 · Cited by 251
Kuhn, J. H., Li, W., Choe, H., & Farzan, M. (2004) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-004-4242-5 · Cited by 249
The coronavirus pandemic in five powerful charts
Callaway, E., Cyranoski, D., Mallapaty, S., Stoye, E., & Tollefson, J. (2020) · Nature · doi:10.1038/d41586-020-00758-2 · Cited by 237
Amirian, E. S., & Levy, J. K. (2020) · One Health · doi:10.1016/j.onehlt.2020.100128 · Cited by 234
Sarma, P., Shekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., Singh, S., Kumar, H., Prakash, A., Dhibar, D. P., et al. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1753580 · Cited by 211
Vitrac, X., Bornet, A., Vanderlinde, R., Valls, J., Richard, T., Delaunay, J.-C., Mérillon, J.-M., & Teissédre, P.-L. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf050122g · Cited by 208
CABS-flex: server for fast simulation of protein structure fluctuations
Jamroz, M., Kolinski, A., & Kmiecik, S. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt332 · Cited by 185
Visualization and analysis of non-covalent contacts using the Protein Contacts Atlas
Kayikci, M., Venkatakrishnan, A. J., Scott-Brown, J., Ravarani, C. N. J., Flock, T., & Babu, M. M. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-017-0019-z · Cited by 161
Journal of Biomolecular Structure and Dynamics
(1996) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.1996.10508903 · Cited by 150
The role of the glycosyl moiety of myricetin derivatives in anti-HIV-1 activity in vitro
Ortega, J. T., Suarez, A. I., Serrano, M. L., Baptista, J., Pujol, F. H., & Rangel, H. R. (2017) · AIDS Research and Therapy · doi:10.1186/s12981-017-0183-6 · Cited by 94
Li, W., Xu, C., Hao, C., Zhang, Y., Wang, Z., Wang, S., & Wang, W. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104714 · Cited by 92
Development of chemical inhibitors of the SARS coronavirus: Viral helicase as a potential target
Keum, Y., & Jeong, Y. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.012 · Cited by 86
Pflieger, A., Téguo, P. W., Papastamoulis, Y., Chaignepain, S., Subra, F., Munir, S., Delelis, O., Lesbats, P., Calmels, C., Andréola, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081184 · Cited by 44
Stefanidou, M., Herrera, C., Armanasco, N., & Shattock, R. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00399-12 · Cited by 24
Cited by
Antiviral activities of flavonoids
Badshah, S. L., Faisal, S., Muhammad, A., Poulson, B. G., Emwas, A. H., & Jaremko, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111596 · Cited by 406
Myricetin: A review of the most recent research
Song, X., Tan, L., Wang, M., Ren, C., Guo, C., Yang, B., Ren, Y., Cao, Z., Li, Y., & Pei, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111017 · Cited by 378
C, S., S., D. K., Ragunathan, V., Tiwari, P., A., S., & P, B. D. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1815584 · Cited by 375
Using X-ray images and deep learning for automated detection of coronavirus disease
El Asnaoui, K., & Chawki, Y. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1767212 · Cited by 360
Roles of flavonoids against coronavirus infection
Russo, M., Moccia, S., Spagnuolo, C., Tedesco, I., & Russo, G. L. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109211 · Cited by 323
Metadata
- Authors
- Joshi, R. S., Jagdale, S. S., Bansode, S. B., Shankar, S. S., Tellis, M. B., Pandya, V. K., Chugh, A., Giri, A. P., & Kulkarni, M. J.
- Venue
- Journal of Biomolecular Structure and Dynamics
- Publisher
- Informa UK Limited
- Published
- 2020-05-05
- Volume
- 39
- Issue
- 9
- Pages
- 1-16
- ISSN
- 0739-1102 (ISSN-L)
- 1538-0254
- OpenAlex
- W3015959833
- Cited by
- 354
- References
- 45
- FWCI
- 37.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.